Search
for

    Sort by

    Research 181–210 of 1000+

    1. SUN-117 A Rare Case of Virilization in a Postmenopausal Woman with Concurrent Hypercalcemia Journal of the Endocrine Society · 2025
    2. Polycystic ovarian syndrome Indian Journal of Dermatology, Venereology and Leprology · 2013 · 27 citations
    3. The impact of minoxidil on male reproductive biology: a multi-approach study including systematic review, in vivo, and ex vivo experiments 2025
    4. PCOS-Management of Androgenetic Alopecia 2024
    5. What every physician should know about polycystic ovary syndrome Dermatologic therapy · 2008 · 33 citations
    6. THE GENETICS OF CYP GENE VARIANTS IN ASSOCIATION WITH POLYCYSTIC OVARY SYNDROME: A NARRATIVE REVIEW Era s journal of medical research · 2024
    7. Polycystic Ovary Syndrome and Its Differential Diagnosis Obstetrical & Gynecological Survey · 2006 · 42 citations
    8. A Clinical Study of Androgenetic Alopecia (III) Annals of Dermatology · 2002 · 4 citations
    9. Integrative Nutritional Mechanisms of Keyora Lycopene 23 in 1 Man's Multi-Vitamin in Erectile Dysfunction, Male Infertility, Prostatic Disorders, and Metabolic Dysregulation Zenodo (CERN European Organization for Nuclear Research) · 2025
    10. Dietary Phytochemicals and their Impact on Androgen Disorders in Males IDOSR JOURNAL OF BIOLOGY CHEMISTRY AND PHARMACY · 2025
    11. RESPOSTA TERAPÊUTICA DA ALOPÉCIA ANDROGENÉTICA APÓS DRUG DELIVERY DIGITAL COM APLICAÇÃO DE PRODEW 500®, NANOFACTOR® AFGF, NANOFACTOR® VEGF, COPPER PEPTÍDEO®, PROHAIRIN B4®, CAPILLISIL HC® E ARCT-ALG® Revista Ibero-Americana de Humanidades, Ciências e Educação · 2021
    12. Biochemical and trichological characterization of diffuse alopecia in women British Journal of Dermatology · 1990 · 124 citations
    13. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Proceedings of the National Academy of Sciences of the United States of America · 1993 · 53 citations
    14. Metabolic syndrome and skin: Psoriasis and beyond Indian Journal of Dermatology · 2013 · 50 citations
    15. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism Archives of Gynecology and Obstetrics · 2006 · 38 citations
    16. Aetiology and Pathophysiology of Hair Loss Dermatology · 1987 · 22 citations
    17. A Clinical Study of Androgenetic Alopecia (V) Journal of Clinical Dermatology · 1995 · 4 citations
    18. Journal Article Zenodo (CERN European Organization for Nuclear Research) · 2026
    19. Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives Cosmetics · 2025
    20. Approach to Alopecia in Dogs in Clinical Practice 2025
    21. The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology Skin appendage disorders · 2024
    22. Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review Revista Eletrônica Acervo Médico · 2022
    23. Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review American Journal of Clinical Dermatology · 2025
    24. Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome Cancer Treatment Reviews · 2023 · 7 citations
    25. The Many Faces of Calcineurin Inhibitor Toxicity—What the FK? Advances in chronic kidney disease · 2020 · 97 citations
    26. [Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women]. PubMed · 1991 · 11 citations
    27. Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients European Journal of Endocrinology · 2025 · 7 citations
    28. Alopecia and hirsutism* Clinical and Experimental Dermatology · 1982 · 6 citations
    29. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026
    30. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026